Insider Stock Trading History of Grant Stuart


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Grant Stuart since year 2005. The trader's CIK number is 1410397. At the time of this reporting, Grant Stuart is the SR VP & CFO of Biocryst Pharmaceuticals Inc . (stock ticker symbol BCRX). See this page for all insider trading activities at Biocryst Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Grant Stuart since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2011-03-16 BCRX Biocryst Pharmaceuticals Inc Option Ex 65,000 1.20 78,000
2011-03-16 BCRX Biocryst Pharmaceuticals Inc Sale 22,615 3.40 76,777
2010-08-04 BCRX Biocryst Pharmaceuticals Inc Sale 2,500 6.20 15,500
2010-08-04 BCRX Biocryst Pharmaceuticals Inc Option Ex 2,500 1.20 3,000
2010-06-03 BCRX Biocryst Pharmaceuticals Inc Sale 1,250 6.97 8,712
2010-06-03 BCRX Biocryst Pharmaceuticals Inc Option Ex 1,250 1.20 1,500
2010-05-03 BCRX Biocryst Pharmaceuticals Inc Option Ex 1,250 1.20 1,500
2010-05-03 BCRX Biocryst Pharmaceuticals Inc Sale 1,250 7.68 9,600
2010-04-28 BCRX Biocryst Pharmaceuticals Inc Sale 1,563 8.26 12,910
2010-04-29 BCRX Biocryst Pharmaceuticals Inc Sale 36,990 8.31 307,386
2010-04-28 BCRX Biocryst Pharmaceuticals Inc Option Ex 1,563 3.26 5,095
2010-04-29 BCRX Biocryst Pharmaceuticals Inc Option Ex 36,990 3.26 120,587
2010-04-12 BCRX Biocryst Pharmaceuticals Inc Option Ex 509 3.26 1,659
2010-04-12 BCRX Biocryst Pharmaceuticals Inc Sale 509 8.26 4,204
2010-04-05 BCRX Biocryst Pharmaceuticals Inc Sale 1,249 6.96 8,699
2010-04-05 BCRX Biocryst Pharmaceuticals Inc Option Ex 1,249 1.20 1,498
2010-03-03 BCRX Biocryst Pharmaceuticals Inc Sale 15,000 6.96 104,370
2010-03-03 BCRX Biocryst Pharmaceuticals Inc Option Ex 15,000 1.20 18,000
2010-01-22 BCRX Biocryst Pharmaceuticals Inc Sale 17,027 7.02 119,529
2009-01-30 BCRX Biocryst Pharmaceuticals Inc Buy 3,000 1.62 4,845
2008-08-04 BCRX Biocryst Pharmaceuticals Inc Buy 3,000 2.82 8,466

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grant Stuart (SR VP & CFO of Biocryst Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.